Results 91 to 100 of about 6,022,305 (300)

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma [PDF]

, 2011
Cisplatin-based chemotherapy is a standard treatment of metastatic urothelial carcinoma (UC), though carboplatin-based chemotherapy is frequently substituted due to improved tolerability.
J. Bellmunt, R. Petrioli, Chen, G J, L. Dogliotti, W.K. Oh, Sonpavde, G, G. J. Chen, B. J. Roth, B.J. Roth, R. Dreicer, Roth, B J, Dreicer, R, Oh, W K, Galsky, M D, M. D. Galsky, Bellmunt, J, W. K. Oh, Petrioli, R, Dogliotti, L, M.D. Galsky, G.J. Chen, G. Sonpavde   +21 more
core   +2 more sources

Who is watching the watchmen: Is quality reporting ever harmful?

SAGE Open Medicine, 2014
Background: Quality reporting is increasingly used as a tool to encourage health systems, hospitals, and their practitioners to deliver the greatest health benefit.
R Scott Braithwaite, Arthur Caplan
doaj   +1 more source

Neurocognitive, School‐Based, and Quality of Life Outcomes for Youth With Sickle Cell Disease and Thalassemia: A Scoping Review

Pediatric Blood &Cancer, EarlyView.
ABSTRACT The medical burdens of sickle cell disease (SCD) and transfusion‐dependent β‐thalassemia (TDT) are chronic and cumulative, even in children. Yet the effects expand beyond medications and healthcare visits due to their impacts on school attendance, academic performance, and peer engagement.
Mary Ann Etling, Hakim Tokhi, Alexander A. Boucher   +2 more
wiley   +1 more source

Making Comparative Effectiveness Research Useful

, 2010
The value of comparative effectiveness research depends on applying appropriate design and analysis principles.
Nichole Carlson
core   +1 more source

Guidance for unbiased predictive information for healthcare decision-making and equity (GUIDE): considerations when race may be a prognostic factor

npj Digital Medicine
Clinical prediction models (CPMs) are tools that compute the risk of an outcome given a set of patient characteristics and are routinely used to inform patients, guide treatment decision-making, and resource allocation. Although much hope has been placed
Keren Ladin, John Cuddeback, O. Kenrik Duru, Sharad Goel, William Harvey, Jinny G. Park, Jessica K. Paulus, Joyce Sackey, Richard Sharp, Ewout Steyerberg, Berk Ustun, David van Klaveren, Saul N. Weingart, David M. Kent   +13 more
doaj   +1 more source

Strengthening capacity for monitoring and evaluation through short course training in Kenya

African Evaluation Journal, 2017
Background: Weak monitoring and evaluation (M&E) systems and limited supply of M&E human resources in Africa signal the need to strengthen M&E capacity.
Hesborn Wao, Rohin Onyango, Elizabeth Kisio, Moses Njatha, Nelson O. Onyango   +4 more
doaj   +1 more source

Lorlatinib‐Containing Therapy for MYCN‐Amplified, ALK‐Mutated Neuroblastoma With Bulky Leptomeningeal Relapse: A Case Report

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia.
Jinwoo Kim, Minji Kim, Nani Jung, Sung Eun Kim, Ji Yoon Kim, Mi Ae Chu, Jung Eun Kwon, Yeo Hyang Kim, So Mi Lee, Ki‐Su Park, Jeong Eun Lee, Ye Jee Shim   +11 more
wiley   +1 more source

National Clinical Effectiveness Committee annual report 2013

, 2014
The National Clinical Effectiveness Committee (NCEC) was established as part of the Patient Safety First Initiative in September 2010. The NCECs mission is to provide a framework for national endorsement of clinical guidelines and audit to optimise ...
National Clinical Effectiveness Committee
core  

The TEAM (Trauma Evaluation and Management) course: medical student knowledge gains and retention in the USA versus Ghana

Trauma Surgery & Acute Care Open, 2019
Introduction Trauma and injury are significant contributors to the global burden of disease, with 5 million deaths and 250 million disability-adjusted life years lost in 2015.
Raul Coimbra, Allison E Berndtson, Martin Morna, Samuel Debrah   +3 more
doaj   +1 more source

Uncovering Inequities: The Role of Social Determinants of Health in Hospitalized Adolescents and Young Adults With Heavy Menstrual Bleeding

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Heavy menstrual bleeding (HMB) is a common condition among adolescents and young adults (AYAs) and is the leading cause of iron deficiency anemia (IDA) in this population. Growing evidence suggests that social determinants of health (SDOH) influence menstrual bleeding patterns, access to care, and treatment. However, no studies have
Maria Carter‐Febres, Cristina Tarango, Ashley Childress, Chunyan Liu, Evan Thomas, Jennifer Pomales, Eric S. Mullins   +6 more
wiley   +1 more source